SK&F 101468-A, A Possible Drug for the Treatment of Parkinson’s Disease

@inproceedings{Costall1990SKF1A,
  title={SK\&F 101468-A, A Possible Drug for the Treatment of Parkinson’s Disease},
  author={Brenda Costall and Rebecca Eden and Carol A. Harvey and M. Elizabeth Kelly and David A. A. Owen},
  year={1990}
}
1 Citations
Chapter 31. To Market, To Market - 1996
TLDR
The central nervous system (CNS) agents were the most active therapeutic area with 11 new launches and anti-neoplastic agents saw the introduction of hycamtin, the first of a new class of drugs that inhibit topoisomerase I. Expand

References

4-[2-(Di-n-propylamino)ethyl]-2(3H)-indolone: a prejunctional dopamine receptor agonist.
4-[2-(Di-n-propylamino)ethyl]-2(3H)-indolone (1c) (SK&F 101468) is a potent and selective prejunctional dopamine receptor agonist. It caused a dose-related inhibition of the constrictor response toExpand